Citadel Advisors
VIVO

Citadel Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Citadel Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,100
Closed -$36.5K – 16160
2022
Q4 		$36.5K Buy
+1,100
New +$35.4K ﹤0.01% 12519
2022
Q3 		– Sell
-11,700
Closed -$356K – 14075
2022
Q2 		$356K Sell
11,700
-6,800
-37% -$184K ﹤0.01% 9428
2022
Q1 		$480K Buy
+18,500
New +$440K ﹤0.01% 9493
2021
Q4 		– Sell
-13,800
Closed -$266K – 15216
2021
Q3 		$266K Sell
13,800
-29,900
-68% -$596K ﹤0.01% 11334
2021
Q2 		$969K Sell
43,700
-1,300
-3% -$27.6K ﹤0.01% 8448
2021
Q1 		$1.18M Buy
45,000
+26,000
+137% +$618K ﹤0.01% 7681
2020
Q4 		$355K Buy
+19,000
New +$355K ﹤0.01% 8772
2020
Q3 		– Sell
-12,400
Closed -$289K – 10983
2020
Q2 		$289K Buy
+12,400
New +$180K ﹤0.01% 7974
2016
Q1 		– Sell
-6,800
Closed -$140K – 8307
2015
Q4 		$140K Sell
6,800
-3,000
-31% -$57.5K ﹤0.01% 6290
2015
Q3 		$168K Buy
9,800
+2,100
+27% +$38.4K ﹤0.01% 6372
2015
Q2 		$144K Sell
7,700
-2,500
-25% -$46.4K ﹤0.01% 6704
2015
Q1 		$195K Buy
10,200
+7,600
+292% +$141K ﹤0.01% 6210
2014
Q4 		$43K Sell
2,600
-7,700
-75% -$132K ﹤0.01% 7310
2014
Q3 		$182K Buy
10,300
+4,700
+84% +$92.3K ﹤0.01% 5818
2014
Q2 		$116K Buy
5,600
+4,500
+409% +$92.5K ﹤0.01% 6114
2014
Q1 		$24K Buy
+1,100
New +$25.2K ﹤0.01% 7215
2013
Q4 		– Sell
-2,000
Closed -$47K – 7218
2013
Q3 		$47K Buy
2,000
+100
+5% +$2.33K ﹤0.01% 5822
2013
Q2 		$41K Buy
+1,900
New +$41K ﹤0.01% 5762

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's VIVO Position: Q1 2023 in Review

Citadel Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 125,670 shares — an estimated $4.17M sold.

Citadel Advisors first reported a position in VIVO in Q2 2013 and held it in 37 quarters. The position peaked at $5.15M in Q2 2016. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Citadel Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 125,670 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.17M.
  • Citadel Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 37 quarters.
  • Citadel Advisors's Meridian Bioscience Inc position peaked at $5.15M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.